A Pharmacoeconomic Evaluation of the Use of Dexrazoxane in Preventing Anthracycline-Induced Cardiotoxicity in Patients with Stage IIIB or IV Metastatic Breast Cancer

Authors: Bates M.; Lieu D.; Zagari M.; Spiers A.; Williamson T.

Source: Clinical Therapeutics, Volume 19, Number 1, January 1997 , pp. 167-184(18)

Publisher: Elsevier

Keywords: dexrazoxane; anthracycline; cardiotoxicity; metastatic breast cancer.

Language: English

Document Type: Research article

DOI: http://dx.doi.org/10.1016/S0149-2918(97)80084-7

Affiliations: 1: aTechnology Assessment Group, San Francisco, California, U.S.A.

Publication date: 1997-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology
• By this author: Bates M. ;  Lieu D. ;  Zagari M. ;  Spiers A. ;  Williamson T.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers